Combined Immune Therapy for the Treatment of Visceral Leishmaniasis - Test2 - elhamkhani - TriplyDB

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

http://www.wikidata.org/entity/Q28550162

about

The immunology of post-kala-azar dermal leishmaniasis (PKDL)A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.Leishmaniasis and various immunotherapeutic approaches.Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis.Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis.

P2860

Q26739701-14270351-1DAD-4628-A0DF-597FEC5377EA Q33724960-21F787D1-77A3-4250-8044-A893B4F5BC2E Q40410089-3317E9BE-DEC7-4DAE-BA2E-E93DA66EF492 Q46080853-5D7D61F1-221F-498F-B2CF-5AB9696EFC47 Q47548487-C041BFA5-6697-44B4-95E2-C1C00BFAF6C7 Q50130388-2980BE9A-A3E8-44E0-94B3-651DDA9D4C8D Q55119887-41C5C8F7-526C-4EC3-B698-DC0B9981950C

P2860

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

http://www.wikidata.org/entity/Q28550162

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@ast

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@en

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@nl

type

label

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@ast

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@en

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@nl

prefLabel

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@ast

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@en

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@nl

P1433

Q28550162-BD7B8258-D1FF-4E87-9280-740B875865D0

P1476

Q28550162-C0225E84-6CBE-4588-80D7-0AF51A71CE9D

P2093

Q28550162-2CF54C9E-39FA-4C0C-BDC9-7E91453C62A6

Q28550162-3BF4461E-941B-44AE-AB4E-BBD3F41C7AC0

Q28550162-4595EE28-A757-47A4-A3C8-AA80A8F216AB

Q28550162-46C218BE-0D35-414B-8060-6112CEF0036E

Q28550162-72879297-2162-409B-97B3-0EF611285343

Q28550162-B7CDE963-2978-4FB2-AEC5-2B7F9FD26F7A

Q28550162-CF7A3C3E-B015-469E-939A-3B54B06D9B38

Q28550162-DACEC9BB-D94F-423B-8E14-89394F90C539

Q28550162-DF7ADF58-50BD-4B08-913E-23426505C8BE

Q28550162-E12468A9-0822-47C1-96D9-A12FB6A285F3

P2860

Q28550162-070E7BF9-993B-4623-AE0E-680A74640546

Q28550162-09F68B93-4962-48ED-8FC3-6078C106C88A

Q28550162-0C69AF9D-7C5B-40CF-A946-E9C416440649

Q28550162-1B8E7A15-B4AD-4B1C-80CE-2F81E4ACAAEE

Q28550162-1DC49680-A16E-4537-86D7-57A639BFC84F

Q28550162-1E296ED9-1A9B-40F7-AF9C-ADDB7F625F15

Q28550162-2151600B-EA29-44FA-8A6D-FE18DF19BF54

Q28550162-2477F429-BB13-4BCA-A4EA-4FE11D31E00B

Q28550162-2A4BECB5-0623-4897-AE0B-32857EBDBF09

Q28550162-306E87F9-06C8-4736-9FEF-985683112181

P304

Q28550162-8F4B3B81-C776-429E-835C-A47D0C64E267

P31

Q28550162-828FC0BF-4FC4-419D-854B-3F64934944FE

P3181

Q28550162-F445D11E-73A9-4A51-8C53-60F0B7EB1648

P356

Q28550162-17C65A71-115C-4041-A899-5B2E523EE1A9

P407

Q28550162-63973E38-117F-4752-90C8-5F6AA0E85C47

P433

Q28550162-D7885582-B9CA-49A1-AA15-C9650EF1FFCB

P478

Q28550162-6D9B6972-587A-4782-992C-450D5A8D41C8

P50

Q28550162-10536D4D-4EDF-4A78-9571-ADDC091E4635

Q28550162-5FD5C330-83C9-4E7E-BD15-DBB8F7DB5E04

Q28550162-688B25E8-0155-46FE-AA55-18BC7E36847F

Q28550162-723C6D3A-CB21-46E9-83E4-95C2633A3612

Q28550162-D58A05F9-95E7-4F05-9973-80B924081BF1

Q28550162-D9AEA201-00EC-4650-B9E2-6F351DC6B1F8

P577

Q28550162-2954E2F2-B4AC-477D-814F-2B7B0B6353FE

P5875

Q28550162-C5834566-04C4-443C-8DAB-BC864C236B4F

P698

Q28550162-E96EB2C6-B4ED-4A89-BED9-7BE7795ABC45

P921

Q28550162-4CCA10AB-D679-4CD8-AF8B-20EB00E17BDE

Q28550162-B1CDEB4B-2EB5-4E9F-9DED-618AC30646D0

P932

Q28550162-BE3603B1-ACAD-4B2A-83C3-CB595DD8D9C2

P3181

P356

JOURNAL.PNTD.0004415

P1433

PLOS Neglected Tropical Diseases

P1476

Combined Immune Therapy for the Treatment of Visceral Leishmaniasis

@en

P2093

Chelsea L Edwards

http://www.w3.org/2001/XMLSchema#string

David Sacks

http://www.w3.org/2001/XMLSchema#string

Fiona H Amante

http://www.w3.org/2001/XMLSchema#string

Louise M Hafner

http://www.w3.org/2001/XMLSchema#string

Lynette Beattie

http://www.w3.org/2001/XMLSchema#string

Marcela Montes de Oca

http://www.w3.org/2001/XMLSchema#string

Neetu Singh

http://www.w3.org/2001/XMLSchema#string

Patrick T Bunn

http://www.w3.org/2001/XMLSchema#string

Rebecca J Faleiro

http://www.w3.org/2001/XMLSchema#string

Shannon E Best

http://www.w3.org/2001/XMLSchema#string

P2860

The Regulation of CD4(+) T Cell Responses during Protozoan Infections

Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis

The blockade of immune checkpoints in cancer immunotherapy

Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)

The future of immune checkpoint therapy

Single-dose liposomal amphotericin B for visceral leishmaniasis in India

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial

The regulation of IL-10 production by immune cells

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection

P304

e0004415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3936641

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PNTD.0004415

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Christian R. Engwerda

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294256844

http://www.w3.org/2001/XMLSchema#string

P698

26872334

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

visceral leishmaniasis

P932

4752322

http://www.w3.org/2001/XMLSchema#string